1 Allenbach Y, Mammen AL, Benveniste O, Stenzel W. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016. Neuromuscul Dis. 2018;28(1):87–99.
2 Weibrecht K, Dayno M, Darling C, Bird SB. Liver Aminotransferases Are Elevated with Rhabdomyolysis in the Absence of Significant Liver Injury. J Med Toxicol. 2010;6(3):294–300.
3 Helfgott SM, Karlson E, Beckman E. Misinterpretation of Serum Transaminase Elevation in «Occult» Myositis. Am J Med. 1993;95(4):447–9.
4 Botros M, Sikaris KA. The De Ritis Ratio: The Test of Time. Clin Biochem Rev. 2013; 34(3):117–30.
5 Sharpe PC, McBride R, Archbold GP. Biochemical markers of alcohol abuse. QJM. 1996;89(2):137–44.
6 Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. Serum Alanine Aminotransferase in Skeletal Muscle Diseases. Hepatology. 2005;41(2):380–2.
7 Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14(5):337–45.
8 Dalakas MC. Inflammatory Muscle Diseases, N Engl J Med. 2015;372:1734–47.
9 Vu HJ, Pham D, Makary R, Nguyen T, Shuja S. Paraneoplastic necrotizing myopathy presenting as severe muscle weakness in a patient with small-cell lung cancer: successful response to chemoradiation therapy. Clin Adv Hematol Oncol. 2011;9(7):557–6.
10 Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344–7.
11 Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–407.
12 Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 2016;139(Pt 8):2131–5.
13 Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy. Autoimmunity Rev. 2019;18(3):223–30.